AJP - Regu Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 288: R401-R408, 2005. First published September 30, 2004; doi:10.1152/ajpregu.00344.2004
0363-6119/05 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/2/R401    most recent
00344.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tatewaki, M.
Right arrow Articles by Takahashi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tatewaki, M.
Right arrow Articles by Takahashi, T.

APPETITE, OBESITY, DIGESTION, AND METABOLISM

Effects of acupuncture on vasopressin-induced emesis in conscious dogs

Makoto Tatewaki,1,2 Carmen Strickland,1 Hiroyuki Fukuda,1 Daisuke Tsuchida,1 Etsuo Hoshino,2 Theodore N. Pappas,1 and Toku Takahashi1

1Department of Surgery, Duke University Medical Center and Veterans Affairs Medical Center, Durham, North Carolina; and 2Department of Internal Medicine, Japanese Foundation for Cancer Research, Tokyo, Japan

Submitted 26 May 2004 ; accepted in final form 21 September 2004


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Although acupuncture has a significant clinical benefit, the mechanism of acupuncture remains unclear. Vasopressin, a posterior pituitary hormone, is involved in nausea and vomiting in humans and dogs. To investigate the antiemetic effects of acupuncture on vasopressin-induced emesis, gastroduodenal motor activity and the frequency of retching and vomiting were simultaneously recorded in conscious dogs. In seven dogs, four force transducers were implanted on the serosal surfaces of the gastric body, antrum, pylorus, and duodenum. Gastroduodenal motility was continuously monitored throughout the experiment. Vasopressin was intravenously infused at a dose of 0.1 U·kg–1·min–1 for 20 min. Electroacupuncture (EA, 1–30 Hz) at pericardium-6 (PC6), bladder-21 (BL21), or stomach-36 (ST36) was performed before, during, and after the vasopressin infusion. To investigate whether the opioid pathway is involved in EA-induced antiemetic effects, naloxone (a central and peripheral opioid receptor antagonist) or naloxone methiodide (a peripheral opioid receptor antagonist) was administered before, during, and after EA and vasopressin infusion. Intravenous infusion of vasopressin induced retching and vomiting in all dogs tested. Retrograde peristaltic contractions occurred before the onset of retching and vomiting. EA (10 Hz) at PC6 significantly reduced the number of episodes of retching and vomiting. EA at PC6 also suppressed retrograde peristaltic contractions. In contrast, EA at BL21 or ST36 had no antiemetic effects. The antiemetic effect of EA was abolished by pretreatment with naloxone but not naloxone methiodide. It is suggested that the antiemetic effect of acupuncture is mediated via the central opioid pathway.

chemoreceptor trigger zone; electroacupuncture; naloxone; retrograde peristaltic contractions; vomiting center

ACUPUNCTURE HAS BEEN USED for various gastrointestinal (GI) conditions. A large body of clinical evidence supports the effectiveness of acupuncture for suppressing nausea associated with chemotherapy, the postoperative state, and pregnancy. Acupuncture has also been used for a variety of other conditions, including postoperative ileus, achalasia, peptic ulcer disease, irritable bowel syndrome, functional dyspepsia (FD), diarrhea, constipation, and inflammatory bowel disease (12). Although acupuncture has been shown to be of significant clinical benefit, the mechanism of the effects of acupuncture still remains unclear.

The most commonly used acupuncture points in treating GI symptoms are the Zusanli point of the lower limbs [stomach-36 (ST36)] and the Neiguan point at the wrists [pericardium-6 (PC6)]. ST36 is located at the proximal one-fifth of craniolateral surface of the leg distal to the head of the tibia in a depression between the muscles of the cranial tibia and the long digital extensor. PC6 is located in the groove caudal to the flexor carpi radialis and cranial to the superficial digital flexor muscles, 3 cm proximal to the corpus.

Several clinical studies have suggested that acupuncture at PC6 is effective for treating and/or preventing emesis associated with surgery, chemotherapy, and motion sickness (1, 3, 13, 15, 16, 37, 40). However, it remains unclear whether the antiemetic effect of acupuncture at PC6 is due to the stimulation of gastric motility and/or the inhibition of activity of the vomiting center.

Emetic stimuli from the GI tract mainly involve the vagus nerve, which has two types of afferent fibers involved in the emetic response. Mechanoreceptors of the vagus are located in the muscular layer, and chemoreceptors of the vagus are located in the mucosal layers of the stomach (5). The chemoreceptor trigger zone (CTZ) is located in the area postrema. CTZ is principally activated by the vagus, phrenic, and spinal nerves, as well as by circulating chemicals. The vomiting center, located in the lateral reticular formation of the medulla oblongata, coordinates efferent impulses through the vagus, phrenic, and spinal nerves of the abdominal musculature during the action of vomiting (4, 41).

Arginine vasopressin (AVP) is a posterior pituitary hormone that has been attributed to functions such as vascular regulation, osmoregulation, stress responses, renal regulation, and neuromodulation. Recent evidence implies that AVP plays a part in vomiting and nausea in humans and animals. The plasma AVP concentration is rapidly elevated in response to diverse emetic stimuli such as motion stimuli (27), apomorphine (33), and cisplatin (11, 17). Treatment with antagonists of the AVP receptor efficiently prevents motion sickness (8, 28). This suggests that endogenous AVP is involved in naturally occurring emesis.

Intravenous injection of AVP results in vomiting and retching in humans (27, 34) and dogs (6, 7). A low dose of exogenous AVP, which has no effect when given peripherally, causes an emetic response when given centrally (25). This suggests that the effects of AVP are mediated via the central nervous system.

Chen et al. (7) recently demonstrated that combined acupuncture at PC6 and ST36 significantly prevented vomiting and reduced the symptoms induced by vasopressin in dogs. The acupoint of ST36 has also been used widely for GI symptoms (12). However, it remains unclear whether acupuncture at ST36 itself has an antiemetic effect.

We studied whether vasopressin-induced emesis was antagonized by acupuncture at PC6 or ST36 in conscious dogs. To investigate the antiemetic effects of acupuncture on vasopressin-induced emesis, gastroduodenal motor activity and the number of retching and vomiting incidents were simultaneously recorded. It has been suggested that the analgesic effect of acupuncture is mediated via the opioid pathway because the antinociceptive effect of acupuncture has been shown to be antagonized by naloxone (12).

To investigate whether the antiemetic effects of EA is mediated via the central or peripheral opioid pathway, we studied the effects of naloxone (a central and peripheral opioid receptor antagonist) and naloxone methiodide (a peripheral opioid receptor antagonist).


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Preparation of animals. All animal experiments were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. All aspects of this research were approved by the Durham Veterans Affairs Medical Center (Durham, NC).

Seven mongrel dogs (five females and two males) weighing between 10 and 20 kg were used in this study. Food was withheld for 12 h before surgery. The dogs were induced with a single intravenous injection of 7 mg/kg body wt of propofol. General anesthesia was maintained by intratracheal inhalation of isoflurane and oxygen. The abdomen was prepared aseptically for a 10-cm ventral midline laparotomy. Four strain-gauge force transducers were implanted on the seromuscular layer to record circular muscle motor activity. Three transducers (8 x 14 mm, model F12IS, Star Medical, Tokyo, Japan) were sutured to the gastric body (at the level of the short gastric artery), the antrum (2–3 cm proximal to the pyloric ring), and the proximal duodenum (3–4 cm distal to the ring), respectively. One additional transducer (4 x 12 mm, model F12IS-P, Star Medical) was applied to the pyloric sphincter. A bundle of lead wires were routed through a subcutaneous tunnel in the costal flank. After the surgery, the lead wires were covered with a jacket protector. The dogs were allowed 2 wk to recover from the surgery.

Acupuncture and vasopressin infusion. Dogs were deprived of food for 12 h before the experiment. The lead wires were connected to a recording system (MacLab, ADInstruments, Colorado Springs, CO). Gastroduodenal motility was continuously monitored throughout the experiment. After phase III of the migrating motor complex cycle was finished, vasopressin infusion was started. Vasopressin was intravenously infused for 20 min at a dose of 0.1 U·kg–1·min–1.

Electroacupuncture (EA, 1–30 Hz) at PC6 or ST36 was performed for 60 min before, during, and after the vasopressin infusion. EA at acupoints located on the back [bladder-21 (BL21)] were used as the location site for sham acupuncture. BL21 is located 1 cm lateral of the spinous process of the 12th thoracic vertebrae.

To investigate the antiemetic effects of EA on vasopressin-induced emesis, gastroduodenal motor activity and the number of retching and vomiting episodes were simultaneously recorded in conscious dogs. The frequency of vasopressin-induced retching and vomiting episodes induced by vasopressin was visually counted during the experiment.

To study the reproducibility of the antiemetic effect of EA at PC6, the same experiments were repeated 1 mo later in each dog.

To investigate whether the opioid pathway was involved in EA-induced antinociceptive effects, naloxone (0.1 mg/kg, bolus plus 0.1 mg·kg–1·h–1 iv) was administered before EA and the vasopressin infusions. Naloxone is able to cross the blood-brain barrier (BBB) and blocks both central and peripheral opioid receptors.

In contrast, naloxone methiodide does not cross the BBB and blocks only peripheral opioid receptors (42). To investigate whether peripheral opioid receptors were involved in EA-induced antiemetic effects, naloxone methiodide (0.5 mg/kg, bolus plus 0.5 mg·kg–1·h–1 iv) was administered before EA and the vasopressin infusion.

Vagal blockade by cooling. As shown in Fig. 1, immediately after the vasopressin infusion, phasic contractions were observed at the duodenum, which were orally migrating to the pylorus and antrum [retrograde peristaltic contractions (RPCs)].



View larger version (27K):
[in this window]
[in a new window]
  		Fig. 1. Gastroduodenal motor responses and retching and vomiting induced by vasopressin. Vasopressin was administered after phase III of the migrating motor complex (MMC) cycle was completed. Intravenous administration of vasopressin (indicated by heavy line at top) induced retching ({circ}) and vomiting ({bullet}). After the vasopressin infusion, retrograde peristaltic contractions (RPCs; indicated by arrows) were observed starting from the duodenum. Retching and vomiting were preceded by antral contractions. Subsequent episodes of retching and vomiting were again preceded by RPCs from the duodenum. The phasic contractions of the body (bottom) reflect the contractions of the diaphragm and abdominal muscles associated with retching and vomiting.

 
To investigate the possible role of vasopressin in RPC mediation, bilateral vagal blockade was performed during vasopressin infusion in four dogs. Bilateral cervical skin flaps were prepared for transient vagal nerve blockade. Under general anesthesia, bilateral skin incisions were made on the ventral neck. Bilateral vagosympathetic nerve trunks with surrounding connective and adipose tissues were isolated, and then a 5-cm portion was wrapped by the skin flap, as previously described (9, 23). The dogs were allowed to recover for 2 wk.

Transient vagal nerve blockade was initiated by circulating absolute ethanol at –20°C through U-shaped copper tubes hooked through the skin loops. The temperature of the wrapped skin was maintained at 4°C. Nerve blockade was achieved within 15–20 min after the start of cooling and was characterized by a deep respiration and bilateral Horner's syndrome, as previously reported (9, 23).

Data and statistical analyses. We calculated the area under the curve during 30 min using a computer-assisted system (MacLab, ADInstruments); this was expressed as a motility index. Values are shown as means ± SE. Statistical analysis was performed by paired t-test or ANOVA. When significant differences were detected by ANOVA, differences between means were checked by Bonferroni's method. P values of <0.05 were considered significant.

Materials. Naloxone and naloxone methiodide were obtained from Sigma (St. Louis, MO). Vasopressin was obtained from American Reagent (Shirley, NY).


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Vasopressin was infused during the period of phase I. Immediately after the vasopressin infusion, phasic contractions were observed at the duodenum, which then orally migrated to the pylorus and antrum (RPCs). Retching and vomiting were frequently observed after RPCs induced by vasopressin in all dogs tested (Fig. 1). During and after the vasopressin infusion, the retching was observed 4.9 ± 0.8 times and vomiting was observed 5.1 ± 0.7 times in each dog (n = 7).

EA (10 Hz) at PC6 was performed before, during, and after the vasopressin infusion for 60 min. EA (10 Hz) at PC6 significantly reduced the number of episodes of retching (1.8 ± 0.2 times) and vomiting (1.6 ± 0.2 times), compared with results without EA (n = 7, P < 0.01, by Bonferroni) (Fig. 2B and Fig. 3). The latency time (15.5 ± 0.8 min, n = 7) to induce retching and/or vomiting after the start of vasopressin infusion was not affected by EA at PC6.



View larger version (25K):
[in this window]
[in a new window]
  		Fig. 2. Effects of electroacupuncture (EA; 10 Hz) on gastric motility induced by vasopressin. EA at pericardium-6 (PC6; B), but not at bladder-21 (BL21; C), significantly attenuated the RPCs as well as the frequency of retching ({circ}) and vomiting ({bullet}) induced by vasopressin. The results were reproducible in 7 different dogs. A: results without EA.

 


View larger version (15K):
[in this window]
[in a new window]
  		Fig. 3. Effects of EA (10 Hz) on the number of retching and vomiting induced by vasopressin (VSP). ST36, stomach-36. Results are means ± SE; n = 7 dogs. *P < 0.05, **P < 0.01; *P < 0.05 vs. vasopressin only (by Bonferroni).

 
Different frequencies (1, 3, 10, and 30 Hz) of EA at PC6 were also performed before, during, and after the vasopressin infusion for 60 min. EA (1–30 Hz) at PC6 decreased the number of retching and vomiting episodes induced by vasopressin in a frequency-dependent manner. The maximum effect was observed at 10 Hz, which showed 34.5 ± 7.9% (n = 7) inhibition of controls (Fig. 4).



View larger version (16K):
[in this window]
[in a new window]
  		Fig. 4. Effects of EA (1–30 Hz) on the number of retching and vomiting episodes induced by vasopressin. Results are means ± SE; n = 7 dogs. *P < 0.05, **P < 0.01 (by Bonferroni).

 
In contrast, EA at BL21 (sham acupuncture) had no significant effects on the number of retching and vomiting episodes (Fig. 2C and Fig. 3). Similarly, EA at ST36 had no significant effects on the number of retching and vomiting episodes induced by vasopressin (Fig. 3).

EA at PC6 also suppressed the RPCs induced by vasopressin (Fig. 2). The motility index of RPCs of the duodenum induced by vasopressin was 1,142 ± 571 g·min, which was significantly reduced to 57 ± 14 g·min by EA at PC6 (n = 7, P < 0.05 by paired t-test). The motility index of RPCs of the antrum induced by vasopressin was 1,863 ± 704 g·min, which was also significantly reduced to 219 ± 74 g·min by EA at PC6 (n = 7, P < 0.05 by paired t-test).

There was a significant correlation observed between the motility index of RPCs of the duodenum and the number of retching and vomiting episodes induced by vasopressin (Fig. 5).



View larger version (16K):
[in this window]
[in a new window]
  		Fig. 5. The correlation between the motility index of RPCs of the duodenum and the number of retching and vomiting episodes induced by vasopressin.

 
The same experiments were repeated 1 mo later in each dog. As shown in Fig. 6A, the vasopressin infusion similarly induced retching and vomiting in the same dog shown in Fig. 2. The antiemetic effects of EA were also observed (Fig. 6B).



View larger version (28K):
[in this window]
[in a new window]
  		Fig. 6. Reproducible effects of EA at PC6 on vasopressin-induced retching ({circ}) and vomiting ({bullet}) and gastrointestinal motility in the absence (A) and presence (B) of EA at PC6. The same experiment shown in Fig. 2 was repeated 1 mo later in the same dog. Results were reproducible in 6 different dogs.

 
Naloxone administration significantly increased the frequency of retching (8.9 ± 1.6 times) and vomiting episodes (7.2 ± 0.8 times) induced by vasopressin, compared with the number of episodes in controls (P < 0.05 by Bonferroni). When naloxone was given during EA and vasopressin infusion, the antiemetic effect of EA was no longer observed (Fig. 3 and Fig. 7A).



View larger version (31K):
[in this window]
[in a new window]
  		Fig. 7. Effects of naloxone (A) and naloxone methiodide (B) on the antiemetic effect of EA at PC6. The antiemetic effect of EA at PC6 was abolished by naloxone (A) but not by naloxone methiodide (B). {circ}, Retching; {bullet}, vomiting. Results were reproducible in seven different dogs.

 
Naloxone methiodide had no effect on the number of retching and vomiting episodes induced by vasopressin, compared with the number of episodes in controls. In contrast to naloxone, naloxone methiodide had no inhibitory effects on the antiemetic effects of EA (Fig. 3 and Fig. 7B). Vagal blockade by cooling was started after phase III of the migrating motor complex cycle was finished. RPCs were no longer observed in response to vasopressin during vagal nerve blockade (Fig. 8). The number of retching (1.3 ± 0.3 times) and vomiting episodes (0.8 ± 0.3 times) in response to vasopressin was significantly reduced, compared with the number of episodes in controls (n = 4, P < 0.05 by paired t-test).



View larger version (13K):
[in this window]
[in a new window]
  		Fig. 8. Effects of vagal blockade on vasopressin-induced RPCs. Vagal cooling was started after phase III of the MMC cycle was completed. Vagal blockade almost completely abolished vasopressin-induced RPCs. The frequency of retching ({circ}) and vomiting ({bullet}) was also significantly reduced by vagal blockade. Results were reproducible in 4 different dogs.

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
Clinical study has demonstrated that EA at PC6 significantly inhibited postoperative nausea and vomiting (19). Acupuncture at PC6 also decreased cisplatin-associated nausea and vomiting (14, 15, 21). EA stimulation reduced gastric tachyarrhythmia in vection-induced motion sickness (24). EA stimulation significantly increased the percentage of regular slow waves, which was sustained in the recovery period in healthy volunteers. The increase of the regular slow-wave activity resulted from the normalization of gastric dysrhythmia. As a result, it is concluded that EA has a role in restoring the regularity of gastric myoelectrical activity (24). However, the mechanism of the antiemetic effect of acupuncture still remains obscure.

Our canine study demonstrated that EA at PC6 significantly antagonized vasopressin-induced retching and vomiting. Vasopressin is believed to act on the CTZ, which serves as a receptor site for chemical agents and may activate the vomiting center (28).

By administering morphine or naloxone systemically and intracerebroventricularly, Costello and Borison (10) demonstrated the opposing emetic and antiemetic actions of opioids in cats. This suggests that morphine has emetic effects as well as antiemetic effects.

The emetic effect of morphine is believed to be at a superficially located CTZ, whereas the antiemetic effect of morphine at the vomiting center is located more deeply in the medulla (18). CTZ is one of the circumventricular organs of the brain, located outside of the BBB and the cerebrospinal fluid barrier. It can be activated by chemical stimuli received through the blood, as well as via the cerebrospinal fluid.

In contrast, the vomiting center is located beneath the solitary tract of the caudal brain stem. Both the emetic and antiemetic effects of morphine can be blocked by naloxone because naloxone can cross the BBB. The antiemetic effect of morphine cannot be blocked by naloxone methiodide because naloxone methiodide does not cross the BBB (42).

It has been demonstrated that a peripheral opioid receptor antagonist combined with morphine blocks apomorphine- and cisplatin-induced emesis in conscious dogs (18). Symptoms of motion sickness are made more severe by the administration of naloxone (2). Our present study also shows that the number of retching and vomiting episodes induced by vasopressin is increased by naloxone but not by naloxone methiodide. These observations suggest that central opioids may play a role in inhibiting the development of emesis. It remains unclear whether the antiemetic effect of central opioid is constitutive or specific to vasopressin.

Several researchers have demonstrated that acupuncture increases opioid levels in humans (12) and in animals (20, 22). We demonstrated that the antiemetic effect of EA at PC6 was antagonized by naloxone but not by naloxone methiodide. This suggests that the antiemetic effect of EA is mediated via the central opioid pathway. It is conceivable that released opioids by EA from the central nervous system play an antiemetic role at the vomiting center. Our in situ hybridization study (unpublished observations) shows that EA upregulates the gene expression of preproenkephalin at the periaqueductal gray in conscious rats. However, we cannot rule out another possibility that EA may interfere with the action of vasopressin on the vomiting center, independently of the opioid pathway.

After vasopressin infusion, RPCs were observed starting from the duodenum. Retching and vomiting were preceded by antral contractions. Subsequent episodes of retching and vomiting were again preceded by RPCs from the duodenum, as shown in Fig. 1.

Similar to our study, retrograde propagation of the spike activity was observed starting from the jejunum by intravenous infusion of dopamine in conscious dogs (30). Apomorphine infusion also caused retrograde giant contractions, which started from the mid-small intestine in conscious dogs (29, 36). Vomiting was observed, followed by strong antral contractions induced by apomorphine (36).

When dopamine infusion failed to change GI motility, retching and vomiting were no longer observed (30). Our vagal blockade study showed that once RPCs have disappeared the frequency of retching and vomiting was significantly attenuated, thus suggesting that the motility changes to RPCs in the GI tract may well be a prerequisite of subsequent occurrences of retching and vomiting.

The vomiting induced by vasopressin infusion was significantly reduced in vagotomized dogs compared with normal dogs (7). We proved that vagal blockade almost completely abolished RPCs and significantly attenuated the episodes of retching and vomiting induced by vasopressin. This suggests that the vagus nerve may have a key role in mediating emesis. Because our present procedure of vagal blockade does not distinguish between efferent and afferent mechanisms, it remains unclear whether the efferent or afferent vagal pathway is involved in mediating emesis induced by vasopressin.

Combined acupuncture at ST36 and PC6 increases the percentage of regular slow waves, resulting in the restoration of gastric dysrhythmia in healthy humans (31). Acupuncture at ST36 has been widely used for various GI symptoms. Although acupuncture at ST36 is well established to stimulate GI motility, it still remains unclear whether acupuncture at ST36 itself has an antiemetic effect.

The impact of acupuncture on upper GI motor activity seems to be variable and dependent on the acupoints used (32, 43). The different effects of EA between PC6 and ST36 on gastric myoelectrical activity have recently been demonstrated in healthy humans (38). EA at PC6 reduced peak dominant power (PDP) to 47% of baselines, whereas EA at ST36 increased PDP to 154% of baseline. Because PDP is associated with the amplitude of gastric contractions, it is suggested that EA at these two acupoints induces either an increase or a decrease in gastric motility (38).

Acupuncture at ST36 stimulates GI contraction via the somatoparasympathetic pathway (35, 39). However, it remains unclear whether acupuncture at PC6 affects GI motility. Our present study suggests that acupuncture at ST36 had no antiemetic effects.

A recent study has indicated that restraint stress causes a fivefold increase of the plasma AVP level in rats (26). Although nausea and vomiting are the common symptoms in patients with FD, it is still unknown whether increased AVP secretion induced by mental stress may mediate the nausea and vomiting in FD patients. Emesis observed in patients with FD may be treatable by acupuncture at PC6.

In conclusion, the frequency of vomiting and retching episodes induced by vasopressin was significantly reduced by acupuncture at PC6, but not by ST36, in conscious dogs. The antiemetic effect of acupuncture was antagonized by naloxone but not by naloxone methiodide. It is suggested that the antiemetic effect of acupuncture at PC6 is mediated via the central opioid pathway.


   ACKNOWLEDGMENTS
 
The authors are indebted to Dr. Gerald Olson, Mary Harris, and Rick Leary for skilled technical assistance at the Durham Veterans Affairs animal facility.


   FOOTNOTES
 

Address for reprint requests and other correspondence: T. Takahashi, Surgical Service 112, VA Medical Center, 508 Fulton St., Durham, NC 27705 (E-mail: ttakahas{at}duke.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Alkaissi A, Stalnert M, and Kalman S. Effect and placebo effect of acupressure (P6) on nausea and vomiting after outpatient gynaecological surgery. Acta Anaesthesiol Scand 43: 270–274, 1999.[CrossRef][Web of Science][Medline]
  2. Allen ME, McKay C, Eaves DM, and Hamilton D. Naloxone enhances motion sickness: endorphins implicated. Aviat Space Environ Med 57: 647–653, 1986.[Medline]
  3. Al-Sadi M, Newman B, and Julious SA. Acupuncture in the prevention of postoperative nausea and vomiting. Anaesthesia 52: 658–661, 1997.[CrossRef][Web of Science][Medline]
  4. Andrews PL. Physiology of nausea and vomiting. Br J Anaesth 69: 2S-19S, 1992.[Medline]
  5. Andrews PL and Wood KL. Vagally mediated gastric motor and emetic reflexes evoked by stimulation of the antral mucosa in anaesthetized ferrets. J Physiol 395: 1–16, 1988.[Abstract/Free Full Text]
  6. Carpenter DO, Briggs DB, and Strominger N. Peptide-induced emesis in dogs. Behav Brain Res 11: 277–281, 1984.[CrossRef][Web of Science][Medline]
  7. Chen JD, Qian L, Ouyang H, and Yin J. Gastric electrical stimulation with short pulses reduces vomiting but not dysrhythmias in dogs. Gastroenterology 124: 401–409, 2003.[CrossRef][Web of Science][Medline]
  8. Cheung BS, Kohl RL, Money KE, and Kinter LB. Etiologic significance of arginine vasopressin in motion sickness. J Clin Pharmacol 34: 664–670, 1994.[Abstract]
  9. Chung SA and Diamant NE. Small intestinal motility in fasted and postprandial states: effect of transient vagosympathetic blockade. Am J Physiol Gastrointest Liver Physiol 252: G301–G308, 1987.[Abstract/Free Full Text]
  10. Costello DJ and Borison HL. Naloxone antagonizes narcotic self blockade of emesis in the cat. J Pharmacol Exp Ther 203: 222–230, 1977.[Abstract/Free Full Text]
  11. Cubeddu LX, Lindley CM, Wetsel W, Carl PL, and Negro-Vilar A. Role of angiotensin II and vasopressin in cisplatin-induced emesis. Life Sci 46: 699–705, 1990.[CrossRef][Web of Science][Medline]
  12. Diehl DL. Acupuncture for gastrointestinal and hepatobiliary disorders. J Altern Complement Med 5: 27–45, 1999.[Web of Science][Medline]
  13. Dundee JW. Belfast experience with P6 acupuncture antiemesis. Ulster Med J 59: 63–70, 1990.[Web of Science][Medline]
  14. Dundee JW, Chestnutt WN, Ghaly RG, and Lynas AG. Traditional Chinese acupuncture: a potentially useful antiemetic? Br Med J 293: 583–584, 1986.[Abstract/Free Full Text]
  15. Dundee JW, Ghaly RG, Bill KM, Chestnutt WN, Fitzpatrick KT, and Lynas AG. Effect of stimulation of the P6 antiemetic point on postoperative nausea and vomiting. Br J Anaesth 63: 612–618, 1989.[Abstract/Free Full Text]
  16. Dundee JW, Yang J, and McMillan C. Non-invasive stimulation of the P6 (Neiguan) antiemetic acupuncture point in cancer chemotherapy. J R Soc Med 84: 210–212, 1991.[Abstract]
  17. Edwards CM, Carmichael J, Baylis PH, and Harris AL. Arginine vasopressin—a mediator of chemotherapy induced emesis? Br J Cancer 59: 467–470, 1989.[Web of Science][Medline]
  18. Foss JF, Yuan CS, Roizen MF, and Goldberg LI. Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine. Cancer Chemother Pharmacol 42: 287–291, 1998.[CrossRef][Web of Science][Medline]
  19. Gan TJ. Postoperative nausea and vomiting—can it be eliminated? JAMA 287: 1233–1236, 2002.[Free Full Text]
  20. Gao M, Wang M, Li K, and He L. Changes of mu opioid receptor binding sites in rat brain following electroacupuncture. Acupunct Electrother Res 22: 161–166, 1997.[Medline]
  21. Ghaly RG, Fitzpatrick KT, and Dundee JW. Antiemetic studies with traditional Chinese acupuncture. A comparison of manual needling with electrical stimulation and commonly used antiemetics. Anaesthesia 42: 1108–1110, 1987.[Web of Science][Medline]
  22. Guo HF, Wang XM, Tian JH, Huo YP, and Han JS. 2 Hz and 100 Hz electroacupuncture accelerate the expression of genes encoding three opioid peptides in the rat brain. Sheng Li Xue Bao 49: 121–127, 1997.[Medline]
  23. Hall KE, el-Sharkawy TY, and Diamant NE. Vagal control of canine postprandial upper gastrointestinal motility. Am J Physiol Gastrointest Liver Physiol 250: G501–G510, 1986.[Abstract/Free Full Text]
  24. Hu S, Stern RM, and Koch KL. Electrical acustimulation relieves vection-induced motion sickness. Gastroenterology 102: 1854–1858, 1992.[Web of Science][Medline]
  25. Ikegaya Y and Matsuki N. Vasopressin induces emesis in Suncus murinus. Jpn J Pharmacol 89: 324–326, 2002.[CrossRef][Medline]
  26. Jorgensen H, Knigge U, Kjaer A, and Warberg J. Serotonergic involvement in stress-induced vasopressin and oxytocin secretion. Eur J Endocrinol 147: 815–824, 2002.[Abstract]
  27. Kim MS, Chey WD, Owyang C, and Hasler WL. Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrhythmias in motion sickness. Am J Physiol Gastrointest Liver Physiol 272: G853–G862, 1997.[Abstract/Free Full Text]
  28. Kohl RL and MacDonald S. New pharmacologic approaches to the prevention of space/motion sickness. J Clin Pharmacol 31: 934–946, 1991.[Abstract]
  29. Lang IM, Sarna SK, and Condon RE. Gastrointestinal motor correlates of vomiting in the dog: quantification and characterization as an independent phenomenon. Gastroenterology 90: 40–47, 1986.[Web of Science][Medline]
  30. Lee KY, Park HJ, and Chey WY. Studies on mechanism of retching and vomiting in dogs. Effect of peripheral dopamine blocker on myoelectric changes in antrum and upper small intestine. Dig Dis Sci 30: 22–28, 1985.[CrossRef][Web of Science][Medline]
  31. Lin X, Liang J, Ren J, Mu F, Zhang M, and Chen JD. Electrical stimulation of acupuncture points enhances gastric myoelectrical activity in humans. Am J Gastroenterol 92: 1527–1530, 1997.[Web of Science][Medline]
  32. Lux G, Hagel J, Backer P, Backer G, Vogl R, Ruppin H, Domschke S, and Domschke W. Acupuncture inhibits vagal gastric acid secretion stimulated by sham feeding in healthy subjects. Gut 35: 1026–1029, 1994.[Abstract/Free Full Text]
  33. Nussey SS, Hawthorn J, Page SR, Ang VT, and Jenkins JS. Responses of plasma oxytocin and arginine vasopressin to nausea induced by apomorphine and ipecacuanha. Clin Endocrinol (Oxf) 28: 297–304, 1988.[Medline]
  34. Rowe JW, Shelton RL, Helderman JH, Vestal RE, and Robertson GL. Influence of the emetic reflex on vasopressin release in man. Kidney Int 16: 729–735, 1979.[Web of Science][Medline]
  35. Sato A, Sato Y, Suzuki A, and Uchida S. Neural mechanisms of the reflex inhibition and excitation of gastric motility elicited by acupuncture-like stimulation in anesthetized rats. Neurosci Res 18: 53–62, 1993.[CrossRef][Web of Science][Medline]
  36. Sha S, Matsushima Y, Habu S, Mishima Y, and Okamoto E. Extrinsic nervous control of retrograde giant contraction during vomiting in conscious dogs. Dig Dis Sci 41: 1546–1550, 1996.[CrossRef][Web of Science][Medline]
  37. Shen J, Wenger N, Glaspy J, Hays RD, Albert PS, Choi C, and Shekelle PG. Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA 284: 2755–2761, 2000.[Abstract/Free Full Text]
  38. Shiotani A, Tatewaki M, Hoshino E, and Takahashi T. Effects of electroacupuncture on gastric myoelectrical activity in healthy humans. Neurogastroenterol Motil 16: 293–298, 2004.[CrossRef][Web of Science][Medline]
  39. Tatewaki M, Harris M, Uemura K, Ueno T, Hoshino E, Shiotani A, Pappas TN, and Takahashi T. Dual effects of acupuncture on gastric motility in conscious rats. Am J Physiol Regul Integr Comp Physiol 285: R862–R872, 2003.[Abstract/Free Full Text]
  40. Wang SM and Kain ZN. P6 acupoint injections are as effective as droperidol in controlling early postoperative nausea and vomiting in children. Anesthesiology 97: 359–366, 2002.[CrossRef][Web of Science][Medline]
  41. Watcha MF and White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 77: 162–184, 1992.[Web of Science][Medline]
  42. Weber TP, Meissner A, Stypmann J, Hartlage MG, Van Aken H, and Rolf N. Naloxone improves splanchnic perfusion in conscious dogs through effects on the central nervous system. Anesthesiology 96: 438–441, 2002.[CrossRef][Web of Science][Medline]
  43. Zhou L and Chey WY. Electric acupuncture stimulates non-parietal cell secretion of the stomach in dog. Life Sci 34: 2233–2238, 1984.[CrossRef][Web of Science][Medline]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Chen, G.-Q. Song, J. Yin, T. Koothan, and J. D. Z. Chen
Electroacupuncture improves impaired gastric motility and slow waves induced by rectal distension in dogs
Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G614 - G620.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Iwa, M. Matsushima, Y. Nakade, T. N. Pappas, M. Fujimiya, and T. Takahashi
Electroacupuncture at ST-36 accelerates colonic motility and transit in freely moving conscious rats
Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G285 - G292.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/2/R401    most recent
00344.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tatewaki, M.
Right arrow Articles by Takahashi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tatewaki, M.
Right arrow Articles by Takahashi, T.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.